Mitchel JT, Kim YJ, Choi J, Park G, Cappi S, Horn D, Kist M, D Agostino RB Jr. Evaluation of Data Entry Errors and Data Changes to an Electronic Data Capture Clinical Trial Database. Drug Inf J. 2011 Jul;45(4):421-430. doi: 10.1177/009286151104500404.
Tan TW, Semaan E, Nasr W, Eberhardt RT, Hamburg N, Doros G, Rybin D, Shaw PM, Farber A. Endovascular revascularization of symptomatic infrapopliteal arteriosclerotic occlusive disease: comparison of atherectomy and angioplasty. Int J Angiol. 2011 Mar;20(1):19-24. doi: 10.1055/s-0031-1272545.
Turchin A, Shubina M, Goldberg S. Unexpected effects of unintended consequences: EMR prescription discrepancies and hemorrhage in patients on warfarin. AMIA Annu Symp Proc. 2011;2011:1412-7. Epub 2011 Oct 22.
Skentzos S, Shubina M, Plutzky J, Turchin A. Structured vs. unstructured: factors affecting adverse drug reaction documentation in an EMR repository. AMIA Annu Symp Proc. 2011;2011:1270-9. Epub 2011 Oct 22.
Granada JF, Price MJ, French PA, Steinhubl SR, Cutlip DE, Becker RC, Smyth SS, Dauerman HL. Platelet-mediated thrombosis and drug-eluting stents. Circ Cardiovasc Interv. 2011 Dec 1;4(6):629-37. doi: 10.1161/CIRCINTERVENTIONS.111.964635.
Kohli P, Cannon CP. Acute coronary syndromes in 2011: Walking the tightrope between efficacy and bleeding. Nat Rev Cardiol. 2011 Dec 20;9(2):69-71. doi: 10.1038/nrcardio.2011.206.
Holm S, Ueland T, Dahl TB, Michelsen AE, Skjelland M, Russell D, Nymo SH, Krohg-Sørensen K, Clausen OP, Atar D, Januzzi JL, Aukrust P, Jensen JK, Halvorsen B. Fatty Acid binding protein 4 is associated with carotid atherosclerosis and outcome in patients with acute ischemic stroke. PLoS One. 2011;6(12):e28785. doi: 10.1371/journal.pone.0028785. Epub 2011 Dec 9.
Reed GW, Cannon CP. Personalized therapy following drug-eluting stenting using platelet function testing and C-reactive protein. J Am Coll Cardiol. 2011 Dec 13;58(25):2640-1. doi: 10.1016/j.jacc.2011.09.031.
Chakrabarti AK, Gibson CM. The SYNTAX score: usefulness, limitations, and future directions. J Invasive Cardiol. 2011 Dec;23(12):511-2.
Navarese EP, Kubica J, Castriota F, Gibson CM, De Luca G, Buffon A, Bolognese L, Margheri M, Andreotti F, Di Mario C, De Servi S. Safety and efficacy of biodegradable vs. durable polymer drug-eluting stents: evidence from a meta-analysis of randomised trials. EuroIntervention. 2011 Dec;7(8):985-94. doi: 10.4244/EIJV7I8A155.
Kohli P, Cannon CP. Statins and safety: can we finally be reassured?. Lancet. 2011 Dec 10;378(9808):1980-1981. doi: 10.1016/S0140-6736(11)61544-4. Epub 2011 Nov 22.
Mauri L, Normand SL, Pencina M, Cutlip DE, Jeon C, Dreyer P, Kuntz RE, Baim DS, Jacobs AK. Rationale and design of the MASS COMM trial: A randomized trial to compare percutaneous coronary intervention between MASSachusetts hospitals with cardiac surgery on-site and COMMunity hospitals without cardiac surgery on-site. Am Heart J. 2011 Nov;162(5):826-31. doi: 10.1016/j.ahj.2011.08.018.
Cannon CP. High-density lipoprotein cholesterol as the Holy Grail. JAMA. 2011 Nov 16;306(19):2153-5. doi: 10.1001/jama.2011.1687.
Canto JG, Kiefe CI, Rogers WJ, Peterson ED, Frederick PD, French WJ, Gibson CM, Pollack CV Jr, Ornato JP, Zalenski RJ, Penney J, Tiefenbrunn AJ, Greenland P; NRMI Investigators. Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction. JAMA. 2011 Nov 16;306(19):2120-7. doi: 10.1001/jama.2011.1654.
Stowell SA, Cannon CP, Hoekstra JW, Peterson ED, Miller SC. Take heart: a one-on-one peer-based strategy to improve acute coronary syndrome patient care. Crit Pathw Cardiol. 2011 Dec;10(4):164-8. doi: 10.1097/HPC.0b013e318236c330.
Yeh RW, Mauri L. Choosing methods to minimize confounding in observational studies: do the ends justify the means?. Circ Cardiovasc Qual Outcomes. 2011 Nov 1;4(6):581-3. doi: 10.1161/CIRCOUTCOMES.111.963538.
Pinto DS, Frederick PD, Chakrabarti AK, Kirtane AJ, Ullman E, Dejam A, Miller DP, Henry TD, Gibson CM; National Registry of Myocardial Infarction Investigators. Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase. Circulation. 2011 Dec 6;124(23):2512-21. doi: 10.1161/CIRCULATIONAHA.111.018549. Epub 2011 Nov 7.
Trivedi NS, Ship AN, Pinto DS. Update: A 43-year-old man with angina, elevated troponin, and lateral ST depression: management of acute coronary syndromes. JAMA. 2011 Nov 2;306(17):1911. doi: 10.1001/jama.2011.1568.
Pascual-Figal DA, Garrido IP, Blanco R, Minguela A, Lax A, Ordoñez-Llanos J, Bayes-Genis A, Valdés M, Moore SA, Januzzi JL. Soluble ST2 is a marker for acute cardiac allograft rejection. Ann Thorac Surg. 2011 Dec;92(6):2118-24. doi: 10.1016/j.athoracsur.2011.07.048. Epub 2011 Oct 28.
Torre M, Carlucci M, Avanzini S, Jasonni V, Monnier P, Tarantino V, D’Agostino R, Vallarino R, Della Rocca M, Moscatelli A, Dehò A, Zannini L, Stagnaro N, Sacco O, Panigada S, Tuo P. Gaslini’s tracheal team: preliminary experience after one year of paediatric airway reconstructive surgery. Ital J Pediatr. 2011 Oct 26;37:51. doi: 10.1186/1824-7288-37-51.
Januzzi JL Jr, Rehman SU, Mohammed AA, Bhardwaj A, Barajas L, Barajas J, Kim HN, Baggish AL, Weiner RB, Chen-Tournoux A, Marshall JE, Moore SA, Carlson WD, Lewis GD, Shin J, Sullivan D, Parks K, Wang TJ, Gregory SA, Uthamalingam S, Semigran MJ. Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction. J Am Coll Cardiol. 2011 Oct 25;58(18):1881-9. doi: 10.1016/j.jacc.2011.03.072.
Eapen ZJ, Fonarow GC, Dai D, O’Brien SM, Schwamm LH, Cannon CP, Heidenreich PA, Bhatt DL, Peterson ED, Hernandez AF; Get With The Guidelines Steering Committee and Hospitals. Comparison of composite measure methodologies for rewarding quality of care: an analysis from the American Heart Association’s Get With The Guidelines program. Circ Cardiovasc Qual Outcomes. 2011 Nov 1;4(6):610-8. doi: 10.1161/CIRCOUTCOMES.111.961391. Epub 2011 Oct 18.
Motivala AA, Cannon CP, Srinivas VS, Dai D, Hernandez AF, Peterson ED, Bhatt DL, Fonarow GC. Changes in myocardial infarction guideline adherence as a function of patient risk: an end to paradoxical care?. J Am Coll Cardiol. 2011 Oct 18;58(17):1760-5. doi: 10.1016/j.jacc.2011.06.050.
Bird GC, Cannon CP, Kennison RH. Results of a survey assessing provider beliefs of adherence barriers to antiplatelet medications. Crit Pathw Cardiol. 2011 Sep;10(3):134-41. doi: 10.1097/HPC.0b013e318230d423.
Acharjee S, Cannon CP. Dabigatran: a new option for anticoagulation in atrial fibrillation and venous thromboembolism. Crit Pathw Cardiol. 2011 Jun;10(2):84-6. doi: 10.1097/HPC.0b013e318224df28.
Venkitachalam L, Lei Y, Magnuson EA, Chan PS, Stolker JM, Kennedy KF, Kleiman NS, Cohen DJ; EVENT Registry Investigators. Survival benefit with drug-eluting stents in observational studies: fact or artifact?. Circ Cardiovasc Qual Outcomes. 2011 Nov 1;4(6):587-94. doi: 10.1161/CIRCOUTCOMES.111.960971. Epub 2011 Oct 11.
Stone JJ, Reynolds MR, Leuthardt EC. Transient hemispatial neglect after surgical resection of a right frontal lobe mass. World Neurosurg. 2011 Sep-Oct;76(3-4):361.e7-10. doi: 10.1016/j.wneu.2010.03.018.
Tan TW, Joglar FL, Hamburg NM, Eberhardt RT, Shaw PM, Rybin D, Doros G, Farber A. Limb outcome and mortality in lower and upper extremity arterial injury: a comparison using the National Trauma Data Bank. Vasc Endovascular Surg. 2011 Oct;45(7):592-7. doi: 10.1177/1538574411415125.
White WB, Bakris GL, Bergenstal RM, Cannon CP, Cushman WC, Fleck P, Heller S, Mehta C, Nissen SE, Perez A, Wilson C, Zannad F. EXamination of cArdiovascular outcoMes with alogliptIN versus standard of carE in patients with type 2 diabetes mellitus and acute coronary syndrome (EXAMINE): a cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes with acute coronary syndrome. Am Heart J. 2011 Oct;162(4):620-626.e1. doi: 10.1016/j.ahj.2011.08.004. Epub 2011 Sep 14.
O’Donoghue ML, Braunwald E, White HD, Serruys P, Steg PG, Hochman J, Maggioni AP, Bode C, Weaver D, Johnson JL, Cicconetti G, Lukas MA, Tarka E, Cannon CP. Study design and rationale for the Stabilization of pLaques usIng Darapladib-Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndrome. Am Heart J. 2011 Oct;162(4):613-619.e1. doi: 10.1016/j.ahj.2011.07.018. Epub 2011 Sep 15.
Lindsey JB, Kennedy KF, Stolker JM, Gilchrist IC, Mukherjee D, Marso SP, Pencina MJ, Kleiman NS, Cohen DJ. Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry. Circ Cardiovasc Interv. 2011 Oct 1;4(5):474-80. doi: 10.1161/CIRCINTERVENTIONS.111.962233. Epub 2011 Oct 4.
Reynolds MR, Zimetbaum P. Magnetic resonance imaging and cardiac devices: how safe is safe enough?. Ann Intern Med. 2011 Oct 4;155(7):470-2. doi: 10.7326/0003-4819-155-7-201110040-00010.
Reynolds MR, Magnuson EA, Lei Y, Leon MB, Smith CR, Svensson LG, Webb JG, Babaliaros VC, Bowers BS, Fearon WF, Herrmann HC, Kapadia S, Kodali SK, Makkar RR, Pichard AD, Cohen DJ; Placement of Aortic Transcatheter Valves (PARTNER) Investigators. Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation. 2011 Nov 1;124(18):1964-72. doi: 10.1161/CIRCULATIONAHA.111.040022. Epub 2011 Oct 3.
Meadows TA, Bhatt DL, Cannon CP, Gersh BJ, Röther J, Goto S, Liau CS, Wilson PW, Salette G, Smith SC, Steg PG; REACH Registry Investigators. Ethnic differences in cardiovascular risks and mortality in atherothrombotic disease: insights from the Reduction of Atherothrombosis for Continued Health (REACH) registry. Mayo Clin Proc. 2011 Oct;86(10):960-7. doi: 10.4065/mcp.2011.0010.
Hsing JM, Selzman KA, Leclercq C, Pires LA, McLaughlin MG, McRae SE, Peterson BJ, Zimetbaum PJ. Paced left ventricular QRS width and ECG parameters predict outcomes after cardiac resynchronization therapy: PROSPECT-ECG substudy. Circ Arrhythm Electrophysiol. 2011 Dec;4(6):851-7. doi: 10.1161/CIRCEP.111.962605. Epub 2011 Sep 28.
Morrison F, Shubina M, Turchin A. Encounter frequency and serum glucose level, blood pressure, and cholesterol level control in patients with diabetes mellitus. Arch Intern Med. 2011 Sep 26;171(17):1542-50. doi: 10.1001/archinternmed.2011.400.
McNulty EJ, Ng W, Spertus JA, Zaroff JG, Yeh RW, Ren XM, Lundstrom RJ. Surgical candidacy and selection biases in nonemergent left main stenting: implications for observational studies. JACC Cardiovasc Interv. 2011 Sep;4(9):1020-7. doi: 10.1016/j.jcin.2011.06.010.
Bhasin S, Jasjua GK, Pencina M, D’Agostino R Sr, Coviello AD, Vasan RS, Travison TG. Sex hormone-binding globulin, but not testosterone, is associated prospectively and independently with incident metabolic syndrome in men: the framingham heart study. Diabetes Care. 2011 Nov;34(11):2464-70. doi: 10.2337/dc11-0888. Epub 2011 Sep 16.
Bis JC, Kavousi M, Franceschini N, Isaacs A, Abecasis GR, Schminke U, Post WS, Smith AV, Cupples LA, Markus HS, Schmidt R, Huffman JE, Lehtimäki T, Baumert J, Münzel T, Heckbert SR, Dehghan A, North K, Oostra B, Bevan S, Stoegerer EM, Hayward C, Raitakari O, Meisinger C, Schillert A, Sanna S, Völzke H, Cheng YC, Thorsson B, Fox CS, Rice K, Rivadeneira F, Nambi V, Halperin E, Petrovic KE, Peltonen L, Wichmann HE, Schnabel RB, Dörr M, Parsa A, Aspelund T, Demissie S, Kathiresan S, Reilly MP, Taylor K, Uitterlinden A, Couper DJ, Sitzer M, Kähönen M, Illig T, Wild PS, Orru M, Lüdemann J, Shuldiner AR, Eiriksdottir G, White CC, Rotter JI, Hofman A, Seissler J, Zeller T, Usala G, Ernst F, Launer LJ, D’Agostino RB Sr, O’Leary DH, Ballantyne C, Thiery J, Ziegler A, Lakatta EG, Chilukoti RK, Harris TB, Wolf PA, Psaty BM, Polak JF, Li X, Rathmann W, Uda M, Boerwinkle E, Klopp N, Schmidt H, Wilson JF, Viikari J, Koenig W, Blankenberg S, Newman AB, Witteman J, Heiss G, Duijn Cv, Scuteri A, Homuth G, Mitchell BD, Gudnason V, O’Donnell CJ; CARDIoGRAM Consortium. Meta-analysis of genome-wide association studies from the CHARGE consortium identifies common variants associated with carotid intima media thickness and plaque. Nat Genet. 2011 Sep 11;43(10):940-7. doi: 10.1038/ng.920.
Yeh RW, Normand SL, Wolf RE, Jones PG, Ho KK, Cohen DJ, Cutlip DE, Mauri L, Kugelmass AD, Amin AP, Spertus JA. Predicting the restenosis benefit of drug-eluting versus bare metal stents in percutaneous coronary intervention. Circulation. 2011 Oct 4;124(14):1557-64. doi: 10.1161/CIRCULATIONAHA.111.045229. Epub 2011 Sep 6.
Mukherji EH, Bauer LK, Leskov I, Januzzi JL, Tanev KS. Safety of antipsychotics in the setting of QTc prolongation: the utility of the JT index. Am J Psychiatry. 2011 Sep;168(9):990-1. doi: 10.1176/appi.ajp.2011.10121734.
Storey RF, Becker RC, Harrington RA, Husted S, James SK, Cools F, Steg PG, Khurmi NS, Emanuelsson H, Lim ST, Cannon CP, Katus HA, Wallentin L. Pulmonary function in patients with acute coronary syndrome treated with ticagrelor or clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] pulmonary function substudy). Am J Cardiol. 2011 Dec 1;108(11):1542-6. doi: 10.1016/j.amjcard.2011.07.015. Epub 2011 Sep 3.
Vojnov L, Martins MA, Almeida JR, Ende Z, Rakasz EG, Reynolds MR, Leon EJ, Weisgrau KL, Burwitz BJ, Folkvord JM, de Santana MG, Neves PC, Connick E, Skinner PJ, Gostick E, O’Connor DH, Wilson NA, Bonaldo MC, Galler R, Price DA, Douek DC, Watkins DI. GagCM9-specific CD8+ T cells expressing limited public TCR clonotypes do not suppress SIV replication in vivo. PLoS One. 2011;6(8):e23515. doi: 10.1371/journal.pone.0023515. Epub 2011 Aug 26.
Polak JF, Pencina MJ, O’Leary DH, D’Agostino RB. Common carotid artery intima-media thickness progression as a predictor of stroke in multi-ethnic study of atherosclerosis. Stroke. 2011 Nov;42(11):3017-21. doi: 10.1161/STROKEAHA.111.625186. Epub 2011 Sep 1.
Bainey KR, Norris CM, Gupta M, Southern D, Galbraith D, Knudtson ML, Graham MM. Altered health status and quality of life in South Asians with coronary artery disease. Am Heart J. 2011 Sep;162(3):501-6. doi: 10.1016/j.ahj.2011.06.009.
Steg PG, Mehta SR, Jukema JW, Lip GY, Gibson CM, Kovar F, Kala P, Garcia-Hernandez A, Renfurm RW, Granger CB; RUBY-1 Investigators. RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome. Eur Heart J. 2011 Oct;32(20):2541-54. doi: 10.1093/eurheartj/ehr334. Epub 2011 Aug 30.
Miller LD, Coffman LG, Chou JW, Black MA, Bergh J, D’Agostino R Jr, Torti SV, Torti FM. An iron regulatory gene signature predicts outcome in breast cancer. Cancer Res. 2011 Nov 1;71(21):6728-37. doi: 10.1158/0008-5472.CAN-11-1870. Epub 2011 Aug 29.
Price MJ, Angiolillo DJ, Teirstein PS, Lillie E, Manoukian SV, Berger PB, Tanguay JF, Cannon CP, Topol EJ. Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trial. Circulation. 2011 Sep 6;124(10):1132-7. doi: 10.1161/CIRCULATIONAHA.111.029165. Epub 2011 Aug 29.
Manzano-Fernández S, Pastor-Pérez FJ, Barquero-Pérez Ó, Pascual-Figal DA, Goya-Esteban R, Rojo-Álvarez JL, Caamaño-Fernández A, Martínez Martínez-Espejo MD, Januzzi JL, Valdés M, García-Alberola A. Short-term variability of heart rate turbulence in chronic heart failure. J Card Fail. 2011 Sep;17(9):735-41. doi: 10.1016/j.cardfail.2011.05.007. Epub 2011 Jun 23.
Venkitachalam L, Lei Y, Stolker JM, Mahoney EM, Amin AP, Lindsey JB, Kennedy KF, Pencina MJ, Lopez JJ, Kleiman NS, Cohen DJ; EVENT Registry Investigators. Clinical and economic outcomes of liberal versus selective drug-eluting stent use: insights from temporal analysis of the multicenter Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry. Circulation. 2011 Aug 30;124(9):1028-37. doi: 10.1161/CIRCULATIONAHA.110.978593. Epub 2011 Aug 15.
Pedersen CA, Gibson CM, Rau SW, Salimi K, Smedley KL, Casey RL, Leserman J, Jarskog LF, Penn DL. Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia. Schizophr Res. 2011 Oct;132(1):50-3. doi: 10.1016/j.schres.2011.07.027. Epub 2011 Aug 15.
Girnius S, Dember L, Doros G, Skinner M. The changing face of AA amyloidosis: a single center experience. Amyloid. 2011 Jun;18 Suppl 1:226-8. doi: 10.3109/13506129.2011.574354085.
Connors LH, Doros G, Sam F, Badiee A, Seldin DC, Skinner M. Clinical features and survival in senile systemic amyloidosis: comparison to familial transthyretin cardiomyopathy. Amyloid. 2011 Jun;18 Suppl 1(Suppl 1):157-9. doi: 10.3109/13506129.2011.574354059.
Seldin DC, Andrea N, Berenbaum I, Berk JL, Connors L, Dember LM, Doros G, Fennessey S, Finn K, Girnius S, Lerner A, Libbey C, Meier-Ewert HK, O’Connell R, O’Hara C, Quillen K, Ruberg FL, Sam F, Segal A, Shelton A, Skinner M, Sloan JM, Wiesman JF, Sanchorawala V. High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution. Amyloid. 2011 Jun;18 Suppl 1(Suppl 1):127-9. doi: 10.3109/13506129.2011.574354047.
Medina HM, Cannon CP, Zhao X, Hernandez AF, Bhatt DL, Peterson ED, Liang L, Fonarow GC. Quality of acute myocardial infarction care and outcomes in 33,997 patients aged 80 years or older: findings from Get With The Guidelines-Coronary Artery Disease (GWTG-CAD). Am Heart J. 2011 Aug;162(2):283-290.e2. doi: 10.1016/j.ahj.2011.04.017.
Bhardwaj A, Truong QA, Peacock WF, Yeo KT, Storrow A, Thomas S, Curtis KM, Foote RS, Lee HK, Miller KF, Januzzi JL Jr. A multicenter comparison of established and emerging cardiac biomarkers for the diagnostic evaluation of chest pain in the emergency department. Am Heart J. 2011 Aug;162(2):276-282.e1. doi: 10.1016/j.ahj.2011.05.022.
Akpek M, Kaya MG, Uyarel H, Yarlioglues M, Kalay N, Gunebakmaz O, Dogdu O, Ardic I, Elcik D, Sahin O, Oguzhan A, Ergin A, Gibson CM. The association of serum uric acid levels on coronary flow in patients with STEMI undergoing primary PCI. Atherosclerosis. 2011 Nov;219(1):334-41. doi: 10.1016/j.atherosclerosis.2011.07.021. Epub 2011 Jul 22.
Cibeira MT, Sanchorawala V, Seldin DC, Quillen K, Berk JL, Dember LM, Segal A, Ruberg F, Meier-Ewert H, Andrea NT, Sloan JM, Finn KT, Doros G, Blade J, Skinner M. Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients. Blood. 2011 Oct 20;118(16):4346-52. doi: 10.1182/blood-2011-01-330738. Epub 2011 Aug 9.
Januzzi JL Jr. Use of biomarkers to “guide” care in chronic heart failure: what have we learned (so far)?. J Card Fail. 2011 Aug;17(8):622-5. doi: 10.1016/j.cardfail.2011.06.373.
Storey RF, Becker RC, Harrington RA, Husted S, James SK, Cools F, Steg PG, Khurmi NS, Emanuelsson H, Cooper A, Cairns R, Cannon CP, Wallentin L. Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes. Eur Heart J. 2011 Dec;32(23):2945-53. doi: 10.1093/eurheartj/ehr231. Epub 2011 Jul 30.
DeFaria Yeh D, Lonergan KL, Fu D, Yeh RW, Echt DS, Foster E. Clinical factors and echocardiographic techniques related to the presence, size, and location of acoustic windows for leadless cardiac pacing. Europace. 2011 Dec;13(12):1760-5. doi: 10.1093/europace/eur199. Epub 2011 Jul 27.
Celik S, Giannitsis E, Wollert KC, Schwöbel K, Lossnitzer D, Hilbel T, Lehrke S, Zdunek D, Hess A, Januzzi JL, Katus HA. Cardiac troponin T concentrations above the 99th percentile value as measured by a new high-sensitivity assay predict long-term prognosis in patients with acute coronary syndromes undergoing routine early invasive strategy. Clin Res Cardiol. 2011 Dec;100(12):1077-85. doi: 10.1007/s00392-011-0344-x. Epub 2011 Jul 27.
Govindarajulu US, Lin H, Lunetta KL, D’Agostino RB Sr. Frailty models: Applications to biomedical and genetic studies. Stat Med. 2011 Sep 30;30(22):2754-64. doi: 10.1002/sim.4277. Epub 2011 Jul 22.
Navarese EP, De Luca G, Castriota F, Kozinski M, Gurbel PA, Gibson CM, Andreotti F, Buffon A, Siller-Matula JM, Sukiennik A, De Servi S, Kubica J. Low-molecular-weight heparins vs. unfractionated heparin in the setting of percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis. J Thromb Haemost. 2011 Oct;9(10):1902-15. doi: 10.1111/j.1538-7836.2011.04445.x.
Polak JF, Pencina MJ, Pencina KM, O’Donnell CJ, Wolf PA, D’Agostino RB Sr. Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med. 2011 Jul 21;365(3):213-21. doi: 10.1056/NEJMoa1012592.
Lovely RS, Yang Q, Massaro JM, Wang J, D’Agostino RB Sr, O’Donnell CJ, Shannon J, Farrell DH. Assessment of genetic determinants of the association of γ’ fibrinogen in relation to cardiovascular disease. Arterioscler Thromb Vasc Biol. 2011 Oct;31(10):2345-52. doi: 10.1161/ATVBAHA.111.232710. Epub 2011 Jul 14.
Pride YB, Gibson CM. Percutaneous coronary interventions in facilities without cardiac surgery on site. Curr Cardiol Rep. 2011 Oct;13(5):432-8. doi: 10.1007/s11886-011-0197-y.
Wu J, Pride YB, Frederick PD, Gibson CM. Association of initial thrombolysis in myocardial infarction flow grade with mortality among patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a National Registry of Myocardial Infarction-5 (NRMI-5) analysis. Am Heart J. 2011 Jul;162(1):178-83. doi: 10.1016/j.ahj.2011.03.018.
Reynolds MR, Sacha JB, Weiler AM, Borchardt GJ, Glidden CE, Sheppard NC, Norante FA, Castrovinci PA, Harris JJ, Robertson HT, Friedrich TC, McDermott AB, Wilson NA, Allison DB, Koff WC, Johnson WE, Watkins DI. The TRIM5{alpha} genotype of rhesus macaques affects acquisition of simian immunodeficiency virus SIVsmE660 infection after repeated limiting-dose intrarectal challenge. J Virol. 2011 Sep;85(18):9637-40. doi: 10.1128/JVI.05074-11. Epub 2011 Jul 6.
Abedi G, Patal P, Doros G, Subramanian ML. Transitioning from stratus OCT to cirrus OCT: a comparison and a proposed equation to convert central subfield macular thickness measurements in healthy subjects. Graefes Arch Clin Exp Ophthalmol. 2011 Sep;249(9):1353-7. doi: 10.1007/s00417-011-1725-6. Epub 2011 Jul 1.
Carbone I, Cannata D, Algeri E, Galea N, Napoli A, De Zorzi A, Bosco G, D’Agostino R, Menezes L, Catalano C, Passariello R, Francone M. Adolescent Kawasaki disease: usefulness of 64-slice CT coronary angiography for follow-up investigation. Pediatr Radiol. 2011 Sep;41(9):1165-73. doi: 10.1007/s00247-011-2141-0. Epub 2011 Jun 30.
Kunadian V, Pride YB, Buros JL, Ciaglo LN, Morrow DA, Gibson CM. Coronary flow reserve varies depending upon the location within the artery it is assessed and the TIMI myocardial perfusion grade: a PROTECT TIMI-30 analysis. J Thromb Thrombolysis. 2011 Nov;32(4):448-52. doi: 10.1007/s11239-011-0617-2.
Mahaffey KW, Wojdyla DM, Carroll K, Becker RC, Storey RF, Angiolillo DJ, Held C, Cannon CP, James S, Pieper KS, Horrow J, Harrington RA, Wallentin L; PLATO Investigators. Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial. Circulation. 2011 Aug 2;124(5):544-54. doi: 10.1161/CIRCULATIONAHA.111.047498. Epub 2011 Jun 27.
Mehta RH, Ferguson TB, Lopes RD, Hafley GE, Mack MJ, Kouchoukos NT, Gibson CM, Harrington RA, Califf RM, Peterson ED, Alexander JH; Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV Investigators. Saphenous vein grafts with multiple versus single distal targets in patients undergoing coronary artery bypass surgery: one-year graft failure and five-year outcomes from the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV trial. Circulation. 2011 Jul 19;124(3):280-8. doi: 10.1161/CIRCULATIONAHA.110.991299. Epub 2011 Jun 27.
D’Agostino RB Sr. Changing end points in breast-cancer drug approval–the Avastin story. N Engl J Med. 2011 Jul 14;365(2):e2. doi: 10.1056/NEJMp1106984. Epub 2011 Jun 27.
Yeh RW, Chandra M, McCulloch CE, Go AS. Accounting for the mortality benefit of drug-eluting stents in percutaneous coronary intervention: a comparison of methods in a retrospective cohort study. BMC Med. 2011 Jun 24;9:78. doi: 10.1186/1741-7015-9-78.
Rubin DJ, Rybin D, Doros G, McDonnell ME. Weight-based, insulin dose-related hypoglycemia in hospitalized patients with diabetes. Diabetes Care. 2011 Aug;34(8):1723-8. doi: 10.2337/dc10-2434. Epub 2011 Jun 23.
Bhasin S, Pencina M, Jasuja GK, Travison TG, Coviello A, Orwoll E, Wang PY, Nielson C, Wu F, Tajar A, Labrie F, Vesper H, Zhang A, Ulloor J, Singh R, D’Agostino R, Vasan RS. Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts. J Clin Endocrinol Metab. 2011 Aug;96(8):2430-9. doi: 10.1210/jc.2010-3012. Epub 2011 Jun 22.
Preiss D, Seshasai SR, Welsh P, Murphy SA, Ho JE, Waters DD, DeMicco DA, Barter P, Cannon CP, Sabatine MS, Braunwald E, Kastelein JJ, de Lemos JA, Blazing MA, Pedersen TR, Tikkanen MJ, Sattar N, Ray KK. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA. 2011 Jun 22;305(24):2556-64. doi: 10.1001/jama.2011.860.
James SK, Roe MT, Cannon CP, Cornel JH, Horrow J, Husted S, Katus H, Morais J, Steg PG, Storey RF, Stevens S, Wallentin L, Harrington RA; PLATO Study Group. Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial. BMJ. 2011 Jun 17;342:d3527. doi: 10.1136/bmj.d3527.
Stone GW, Vora K, Schindler J, Diaz C, Mann T, Dangas G, Best P, Cutlip DE; COOL-RCN Investigators. Systemic hypothermia to prevent radiocontrast nephropathy (from the COOL-RCN Randomized Trial). Am J Cardiol. 2011 Sep 1;108(5):741-6. doi: 10.1016/j.amjcard.2011.04.026. Epub 2011 Jun 15.
Karakas M, Januzzi JL Jr, Meyer J, Lee H, Schlett CL, Truong QA, Rottbauer W, Bamberg F, Dasdemir S, Hoffmann U, Koenig W. Copeptin does not add diagnostic information to high-sensitivity troponin T in low- to intermediate-risk patients with acute chest pain: results from the rule out myocardial infarction by computed tomography (ROMICAT) study. Clin Chem. 2011 Aug;57(8):1137-45. doi: 10.1373/clinchem.2010.160192. Epub 2011 Jun 14.
Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, White H. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011 Jun 14;123(23):2736-47. doi: 10.1161/CIRCULATIONAHA.110.009449.
Baggish AL, Wood MJ. Athlete’s heart and cardiovascular care of the athlete: scientific and clinical update. Circulation. 2011 Jun 14;123(23):2723-35. doi: 10.1161/CIRCULATIONAHA.110.981571.
Maron MS, Olivotto I, Harrigan C, Appelbaum E, Gibson CM, Lesser JR, Haas TS, Udelson JE, Manning WJ, Maron BJ. Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy. Circulation. 2011 Jul 5;124(1):40-7. doi: 10.1161/CIRCULATIONAHA.110.985812. Epub 2011 Jun 13.
Burke AR, Singh RN, Carroll DL, Owen JD, Kock ND, D’Agostino R Jr, Torti FM, Torti SV. Determinants of the thrombogenic potential of multiwalled carbon nanotubes. Biomaterials. 2011 Sep;32(26):5970-8. doi: 10.1016/j.biomaterials.2011.04.059. Epub 2011 Jun 12.
Rocha-Singh KJ, Novack V, Pencina M, D’Agostino R, Ansel G, Rosenfield K, Jaff MR. Objective performance goals of safety and blood pressure efficacy for clinical trials of renal artery bare metal stents in hypertensive patients with atherosclerotic renal artery stenosis. Catheter Cardiovasc Interv. 2011 Nov 1;78(5):779-89. doi: 10.1002/ccd.23055. Epub 2011 Jun 6.
Cutlip DE. Five-year outcomes of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: are they equally good (or bad)?. Circulation. 2011 Jun 21;123(24):2779-81. doi: 10.1161/CIRCULATIONAHA.111.033654. Epub 2011 Jun 6.
Wilson SR, Sabatine MS, Wiviott SD, Ray KK, De Lemos JA, Zhou S, Rifai N, Cannon CP, Morrow DA; TIMI Study Group. Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22). Am Heart J. 2011 Jun;161(6):1147-55.e1. doi: 10.1016/j.ahj.2011.02.014. Epub 2011 May 11.
Amin AP, Kennedy KF, Pencina M, Berger P, Piana RN, Lopez J, Kleiman N, Cohen DJ; EVENT Investigators. Effect of clopidogrel pretreatment on ischemic complications of percutaneous coronary intervention among bivalirudin-treated patients (from the EVENT registry). Am J Cardiol. 2011 Jun 15;107(12):1751-6. doi: 10.1016/j.amjcard.2011.02.331.
El-Armouche A, Ouchi N, Tanaka K, Doros G, Wittköpper K, Schulze T, Eschenhagen T, Walsh K, Sam F. Follistatin-like 1 in chronic systolic heart failure: a marker of left ventricular remodeling. Circ Heart Fail. 2011 Sep;4(5):621-7. doi: 10.1161/CIRCHEARTFAILURE.110.960625. Epub 2011 May 27.
Rosas HD, Reuter M, Doros G, Lee SY, Triggs T, Malarick K, Fischl B, Salat DH, Hersch SM. A tale of two factors: what determines the rate of progression in Huntington’s disease? A longitudinal MRI study. Mov Disord. 2011 Aug 1;26(9):1691-7. doi: 10.1002/mds.23762. Epub 2011 May 24.
Blackshear JL, Cutlip DE, Roubin GS, Hill MD, Leimgruber PP, Begg RJ, Cohen DJ, Eidt JF, Narins CR, Prineas RJ, Glasser SP, Voeks JH, Brott TG; CREST Investigators. Myocardial infarction after carotid stenting and endarterectomy: results from the carotid revascularization endarterectomy versus stenting trial. Circulation. 2011 Jun 7;123(22):2571-8. doi: 10.1161/CIRCULATIONAHA.110.008250. Epub 2011 May 23.
Turchin A, Goldberg SI, Breydo E, Shubina M, Einbinder JS. Copy/paste documentation of lifestyle counseling and glycemic control in patients with diabetes: true to form?. Arch Intern Med. 2011 Aug 8;171(15):1393-4. doi: 10.1001/archinternmed.2011.219. Epub 2011 May 23.
Weiner RB, Hutter AM, Wang F, Kim JH, Wood MJ, Wang TJ, Picard MH, Baggish AL. Performance of the 2010 European Society of Cardiology criteria for ECG interpretation in athletes. Heart. 2011 Oct;97(19):1573-7. doi: 10.1136/hrt.2011.227330. Epub 2011 May 20.
McCall WV, D’Agostino R Jr, Rosenquist PB, Kimball J, Boggs N, Lasater B, Blocker J. Dissection of the factors driving the placebo effect in hypnotic treatment of depressed insomniacs. Sleep Med. 2011 Jun;12(6):557-64. doi: 10.1016/j.sleep.2011.03.008. Epub 2011 May 20.
Krucoff MW, Mehran R, van Es GA, Boam AB, Cutlip DE. The academic research consortium governance charter. JACC Cardiovasc Interv. 2011 May;4(5):595-6. doi: 10.1016/j.jcin.2011.03.008.
Cutlip DE, Nakazawa G, Krucoff MW, Vorpahl M, Mehran R, Finn AV, Vranckx P, Kimmelstiel C, Berger C, Petersen JL, Palabrica T, Virmani R. Autopsy validation study of the academic research consortium stent thrombosis definition. JACC Cardiovasc Interv. 2011 May;4(5):554-9. doi: 10.1016/j.jcin.2011.01.011.
Kandzari DE, Mauri L, Popma JJ, Turco MA, Gurbel PA, Fitzgerald PJ, Leon MB. Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). JACC Cardiovasc Interv. 2011 May;4(5):543-50. doi: 10.1016/j.jcin.2010.12.014.
Stone GW, Ellis SG, Colombo A, Grube E, Popma JJ, Uchida T, Bleuit JS, Dawkins KD, Russell ME. Long-term safety and efficacy of paclitaxel-eluting stents final 5-year analysis from the TAXUS Clinical Trial Program. JACC Cardiovasc Interv. 2011 May;4(5):530-42. doi: 10.1016/j.jcin.2011.03.005.
Rutzen-Lopez H, Khanna V, Reynolds MR. Atrial fibrillation: epidemiology, prognosis and therapy. Minerva Med. 2011 Jun;102(3):187-207.
Martins MA, Gheno JL, Sant’Ana Filho M, Pinto DS Jr, Tenis CA, Martins MD. Rare case of unifocal Langerhans cell histiocytosis in four-month-old child. Int J Pediatr Otorhinolaryngol. 2011 Jul;75(7):963-7. doi: 10.1016/j.ijporl.2011.04.009. Epub 2011 May 17.
Gibson CM, Mega JL, Burton P, Goto S, Verheugt F, Bode C, Plotnikov A, Sun X, Cook-Bruns N, Braunwald E. Rationale and design of the Anti-Xa therapy to lower cardiovascular events in addition to standard therapy in subjects with acute coronary syndrome-thrombolysis in myocardial infarction 51 (ATLAS-ACS 2 TIMI 51) trial: a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome. Am Heart J. 2011 May;161(5):815-821.e6. doi: 10.1016/j.ahj.2011.01.026.
Mauri L, Leon MB, Yeung AC, Negoita M, Keyes MJ, Massaro JM. Rationale and design of the clinical evaluation of the Resolute Zotarolimus-Eluting Coronary Stent System in the treatment of de novo lesions in native coronary arteries (the RESOLUTE US clinical trial). Am Heart J. 2011 May;161(5):807-14. doi: 10.1016/j.ahj.2011.03.015. Epub 2011 Mar 29.
Cannon CP, Hoekstra JW, Larson DM, Karcher RB, Mencia WA, Berry CA, Stowell SA. A report of quality improvement in the care of patients with acute coronary syndromes. Crit Pathw Cardiol. 2011 Mar;10(1):29-34. doi: 10.1097/HPC.0b013e318204eb8b.
Kim HN, Januzzi JL Jr. Natriuretic peptide testing in heart failure. Circulation. 2011 May 10;123(18):2015-9. doi: 10.1161/CIRCULATIONAHA.110.979500.
Pascual-Figal DA, Manzano-Fernández S, Boronat M, Casas T, Garrido IP, Bonaque JC, Pastor-Perez F, Valdés M, Januzzi JL. Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure. Eur J Heart Fail. 2011 Jul;13(7):718-25. doi: 10.1093/eurjhf/hfr047. Epub 2011 May 6.
Klein LW, Ho KK, Singh M, Anderson HV, Hillegass WB, Uretsky BF, Chambers C, Rao SV, Reilly J, Weiner BH, Kern M, Bailey S; Society of Cardiovascular Angiography and Interventions. Quality assessment and improvement in interventional cardiology: a Position Statement of the Society of Cardiovascular Angiography and Interventions, Part II: public reporting and risk adjustment. Catheter Cardiovasc Interv. 2011 Oct 1;78(4):493-502. doi: 10.1002/ccd.23153. Epub 2011 May 5.
Kotowycz MA, Filion KB, Joza J, Dube D, Reynolds MR, Pilote L, Eisenberg MJ, Essebag V. In-hospital management of atrial fibrillation: the CHADS₂ score predicts increased cost. Can J Cardiol. 2011 Jul-Aug;27(4):506-13. doi: 10.1016/j.cjca.2011.01.002. Epub 2011 May 4.
Scirica BM, Cannon CP, Emanuelsson H, Michelson EL, Harrington RA, Husted S, James S, Katus H, Pais P, Raev D, Spinar J, Steg PG, Storey RF, Wallentin L; PLATO Investigators. The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: results of the continuous electrocardiographic assessment substudy. J Am Coll Cardiol. 2011 May 10;57(19):1908-16. doi: 10.1016/j.jacc.2010.11.056.
Stone GW, Rizvi A, Sudhir K, Newman W, Applegate RJ, Cannon LA, Maddux JT, Cutlip DE, Simonton CA, Sood P, Kereiakes DJ; SPIRIT IV Investigators. Randomized comparison of everolimus- and paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial. J Am Coll Cardiol. 2011 Jun 28;58(1):19-25. doi: 10.1016/j.jacc.2011.02.022. Epub 2011 Apr 21.
Reynolds MR, Ray WZ, Strom RG, Blackburn SL, Lee A, Park TS. Clinical outcomes after selective dorsal rhizotomy in an adult population. World Neurosurg. 2011 Jan;75(1):138-44. doi: 10.1016/j.wneu.2010.09.010.
Truong QA, Murphy SA, McCabe CH, Armani A, Cannon CP; TIMI Study Group. Benefit of intensive statin therapy in women: results from PROVE IT-TIMI 22. Circ Cardiovasc Qual Outcomes. 2011 May;4(3):328-36. doi: 10.1161/CIRCOUTCOMES.110.957720. Epub 2011 Apr 12.
Schnipper JL, Liang CL, Hamann C, Karson AS, Palchuk MB, McCarthy PC, Sherlock M, Turchin A, Bates DW. Development of a tool within the electronic medical record to facilitate medication reconciliation after hospital discharge. J Am Med Inform Assoc. 2011 May 1;18(3):309-13. doi: 10.1136/amiajnl-2010-000040.
Uno H, Cai T, Pencina MJ, D’Agostino RB, Wei LJ. On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. Stat Med. 2011 May 10;30(10):1105-17. doi: 10.1002/sim.4154. Epub 2011 Jan 13.
Fiore LD, Brophy M, Ferguson RE, D’Avolio L, Hermos JA, Lew RA, Doros G, Conrad CH, O’Neil JA Jr, Sabin TP, Kaufman J, Swartz SL, Lawler E, Liang MH, Gaziano JM, Lavori PW. A point-of-care clinical trial comparing insulin administered using a sliding scale versus a weight-based regimen. Clin Trials. 2011 Apr;8(2):183-95. doi: 10.1177/1740774511398368.
Bainey KR, Lai TF, Mehta SR. Clopidogrel in acute coronary syndromes: where are we now?. Thromb Haemost. 2011 May;105(5):766-73. doi: 10.1160/TH10-10-0633. Epub 2011 Apr 7.
Yeung AC, Leon MB, Jain A, Tolleson TR, Spriggs DJ, Mc Laurin BT, Popma JJ, Fitzgerald PJ, Cutlip DE, Massaro JM, Mauri L; RESOLUTE US Investigators. Clinical evaluation of the Resolute zotarolimus-eluting coronary stent system in the treatment of de novo lesions in native coronary arteries: the RESOLUTE US clinical trial. J Am Coll Cardiol. 2011 Apr 26;57(17):1778-83. doi: 10.1016/j.jacc.2011.03.005. Epub 2011 Apr 4.
Pascual-Figal DA, Sanchez-Mas J, Januzzi JL. Eplerenone in mild heart failure. N Engl J Med. 2011 Apr 7;364(14):1370; author reply 1372. doi: 10.1056/NEJMc1101287.
Lee-Lewandrowski E, Januzzi JL Jr, Grisson R, Mohammed AA, Lewandrowski G, Lewandrowski K. Evaluation of first-draw whole blood, point-of-care cardiac markers in the context of the universal definition of myocardial infarction: a comparison of a multimarker panel to troponin alone and to testing in the central laboratory. Arch Pathol Lab Med. 2011 Apr;135(4):459-63. doi: 10.1043/2010-0112-OA.1.
Patti G, Cannon CP, Murphy SA, Mega S, Pasceri V, Briguori C, Colombo A, Yun KH, Jeong MH, Kim JS, Choi D, Bozbas H, Kinoshita M, Fukuda K, Jia XW, Hara H, Cay S, Di Sciascio G. Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studies. Circulation. 2011 Apr 19;123(15):1622-32. doi: 10.1161/CIRCULATIONAHA.110.002451. Epub 2011 Apr 4.
Ruff CT, Morrow DA, Jarolim P, Ren F, Contant CF, Kaur A, Curtis SP, Laine L, Cannon CP, Brune K. Evaluation of NT-proBNP and high sensitivity C-reactive protein for predicting cardiovascular risk in patients with arthritis taking longterm nonsteroidal antiinflammatory drugs. J Rheumatol. 2011 Jun;38(6):1071-8. doi: 10.3899/jrheum.100880. Epub 2011 Apr 1.
Chan PS, Brindis RG, Cohen DJ, Jones PG, Gialde E, Bach RG, Curtis J, Bethea CF, Shelton ME, Spertus JA. Concordance of physician ratings with the appropriate use criteria for coronary revascularization. J Am Coll Cardiol. 2011 Apr 5;57(14):1546-53. doi: 10.1016/j.jacc.2010.10.050.
Januzzi JL. What is the role of biomarker measurement after cardiac surgery?. Minerva Anestesiol. 2011 Mar;77(3):334-41.
Hartzell M, Malhotra R, Yared K, Rosenfield HR, Walker JD, Wood MJ. Effect of gender on treatment and outcomes in severe aortic stenosis. Am J Cardiol. 2011 Jun 1;107(11):1681-6. doi: 10.1016/j.amjcard.2011.01.059. Epub 2011 Mar 26.
Zachariah JP, Pencina MJ, Lyass A, Kaur G, D’Agostino RB, Ordovas JM, Vasan RS. Circulating plasma cholesteryl ester transfer protein activity and blood pressure tracking in the community. J Hypertens. 2011 May;29(5):863-8. doi: 10.1097/HJH.0b013e3283450223.
Ciccone MM, Cortese F, Fiorella A, Scicchitano P, Cito F, Quistelli G, Pertosa G, D’Agostino R, Guida P, Favale S. The clinical role of contrast-enhanced ultrasound in the evaluation of renal artery stenosis and diagnostic superiority as compared to traditional echo-color-Doppler flow imaging. Int Angiol. 2011 Apr;30(2):135-9.
Yeh RW, Kennedy K, Spertus JA, Parikh SA, Sakhuja R, Anderson HV, White CJ, Rosenfield K. Do postmarketing surveillance studies represent real-world populations? A comparison of patient characteristics and outcomes after carotid artery stenting. Circulation. 2011 Apr 5;123(13):1384-90. doi: 10.1161/CIRCULATIONAHA.110.991075. Epub 2011 Mar 21.
Abtahian F, Olenchock B, Ou FS, Kontos MC, Saucedo JF, Scirica BM, Desai N, Peterson E, Roe M, Cannon CP, Wiviott SD. Effect of prior stroke on the use of evidence-based therapies and in-hospital outcomes in patients with myocardial infarction (from the NCDR ACTION GWTG registry). Am J Cardiol. 2011 May 15;107(10):1441-6. doi: 10.1016/j.amjcard.2011.01.020. Epub 2011 Mar 21.
Di Mundo R, Nardulli M, Milella A, Favia P, d’Agostino R, Gristina R. Cell adhesion on nanotextured slippery superhydrophobic substrates. Langmuir. 2011 Apr 19;27(8):4914-21. doi: 10.1021/la200136t. Epub 2011 Mar 17.
Elmariah S, Lubitz SA, Shah AM, Miller MA, Kaplish D, Kothari S, Moreno PR, Kini AS, Sharma SK. A novel clinical prediction rule for 30-day mortality following balloon aortic valuloplasty: the CRRAC the AV score. Catheter Cardiovasc Interv. 2011 Jul 1;78(1):112-8. doi: 10.1002/ccd.22912. Epub 2011 Mar 16.
Murphy TP, Dhangana R, Pencina MJ, Zafar AM, D’Agostino RB. Performance of current guidelines for coronary heart disease prevention: optimal use of the Framingham-based risk assessment. Atherosclerosis. 2011 Jun;216(2):452-7. doi: 10.1016/j.atherosclerosis.2011.02.020. Epub 2011 Feb 18.
Cohen DJ, Van Hout B, Serruys PW, Mohr FW, Macaya C, den Heijer P, Vrakking MM, Wang K, Mahoney EM, Audi S, Leadley K, Dawkins KD, Kappetein AP; Synergy between PCI with Taxus and Cardiac Surgery Investigators. Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery. N Engl J Med. 2011 Mar 17;364(11):1016-26. doi: 10.1056/NEJMoa1001508.
Kleinman NL, Rohrbacker NJ, White SA, March JL, Reynolds MR. Economic impact to employers of treatment options for cardiac arrhythmias in the US health system. J Occup Environ Med. 2011 Apr;53(4):405-14. doi: 10.1097/JOM.0b013e31820fd1c9.
Price MJ, Berger PB, Teirstein PS, Tanguay JF, Angiolillo DJ, Spriggs D, Puri S, Robbins M, Garratt KN, Bertrand OF, Stillabower ME, Aragon JR, Kandzari DE, Stinis CT, Lee MS, Manoukian SV, Cannon CP, Schork NJ, Topol EJ; GRAVITAS Investigators. Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. JAMA. 2011 Mar 16;305(11):1097-105. doi: 10.1001/jama.2011.290.
Natarajan P, Cannon CP. Myocardial infarction vaccine? Evidence supporting the influenza vaccine for secondary prevention. Eur Heart J. 2011 Jul;32(14):1701-3. doi: 10.1093/eurheartj/ehr053. Epub 2011 Mar 15.
Javed U, Deedwania PC, Bhatt DL, Cannon CP, Dai D, Hernandez A, Peterson ED, Fonarow GC. Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: An analysis of 65,396 hospitalizations from 344 hospita participating in Get With The Guidelines (GWTG). Am Heart J. 2011 Feb;161(2):418-424.e1-3. doi: 10.1016/j.ahj.2010.12.014.
Cannon CP. Clopidogrel: to test or not to test? That is the question–still. Clin Chem. 2011 May;57(5):659-61. doi: 10.1373/clinchem.2010.158709. Epub 2011 Mar 14.
Manzano-Fernández S, Januzzi JL, Boronat García M, Bonaque-González JC, Muñoz-Esparza C, Albaladejo-Otón MD, Pastor-Pérez FJ, Pastor P, Valdés M, Pascual-Figal DA. [Comparative prognostic value of plasma and urinary N-terminal pro-B-type natriuretic peptide in patients with acute destabilized heart failure]. Rev Esp Cardiol. 2011 May;64(5):365-72. doi: 10.1016/j.recesp.2010.10.017. Epub 2011 Mar 11.
Cicek G, Uyarel H, Ergelen M, Ayhan E, Abanonu GB, Eren M, Gibson CM. Hemoglobin A1c as a prognostic marker in patients undergoing primary angioplasty for acute myocardial infarction. Coron Artery Dis. 2011 May;22(3):131-7. doi: 10.1097/MCA.0b013e328342c760.
Gibson CM, Maehara A, Lansky AJ, Wohrle J, Stuckey T, Dave R, Cox D, Grines C, Dudek D, Steg G, Parise H, Wolff SD, Cristea E, Stone GW. Rationale and design of the INFUSE-AMI study: A 2 × 2 factorial, randomized, multicenter, single-blind evaluation of intracoronary abciximab infusion and aspiration thrombectomy in patients undergoing percutaneous coronary intervention for anterior ST-segment elevation myocardial infarction. Am Heart J. 2011 Mar;161(3):478-486.e7. doi: 10.1016/j.ahj.2010.10.006. Epub 2011 Jan 28.
Otake H, Honda Y, Courtney BK, Shimohama T, Ako J, Waseda K, Macours N, Rogers C, Popma JJ, Abizaid A, Ormiston JA, Spaulding C, Cohen SA, Fitzgerald PJ. Intravascular ultrasound results from the NEVO ResElution-I trial: a randomized, blinded comparison of sirolimus-eluting NEVO stents with paclitaxel-eluting TAXUS Liberté stents in de novo native coronary artery lesions. Circ Cardiovasc Interv. 2011 Apr 1;4(2):146-54. doi: 10.1161/CIRCINTERVENTIONS.110.957175. Epub 2011 Mar 8.
Huffman JC, Mastromauro CA, Sowden G, Fricchione GL, Healy BC, Januzzi JL. Impact of a depression care management program for hospitalized cardiac patients. Circ Cardiovasc Qual Outcomes. 2011 Mar;4(2):198-205. doi: 10.1161/CIRCOUTCOMES.110.959379. Epub 2011 Mar 8.
Sawaya H, Sebag IA, Plana JC, Januzzi JL, Ky B, Cohen V, Gosavi S, Carver JR, Wiegers SE, Martin RP, Picard MH, Gerszten RE, Halpern EF, Passeri J, Kuter I, Scherrer-Crosbie M. Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am J Cardiol. 2011 May 1;107(9):1375-80. doi: 10.1016/j.amjcard.2011.01.006. Epub 2011 Mar 2.
Klein LW, Uretsky BF, Chambers C, Anderson HV, Hillegass WB, Singh M, Ho KK, Rao SV, Reilly J, Weiner BH, Kern M, Bailey S; Society of Cardiovascular Angiography and Interventions. Quality assessment and improvement in interventional cardiology: a position statement of the Society of Cardiovascular Angiography and Interventions, part 1: standards for quality assessment and improvement in interventional cardiology. Catheter Cardiovasc Interv. 2011 Jun 1;77(7):927-35. doi: 10.1002/ccd.22982. Epub 2011 Mar 2.
Saito S, Prpic R, Popma JJ, Alexander J, Krucoff MW; ENDEAVOR Japan Investigators. The clinical evaluation of the Endeavor zotarolimus-eluting coronary stent in Japanese patients with de novo native coronary artery lesions: primary results and 3-year follow-up of the Endeavor Japan study. Cardiovasc Revasc Med. 2011 Sep-Oct;12(5):273-9. doi: 10.1016/j.carrev.2010.12.007. Epub 2011 Mar 1.
Selker HP, Beshansky JR, Ruthazer R, Sheehan PR, Sayah AJ, Atkins JM, Aufderheide TP, Pirrallo RG, D’Agostino RB, Massaro JM, Griffith JL. Emergency medical service predictive instrument-aided diagnosis and treatment of acute coronary syndromes and ST-segment elevation myocardial infarction in the IMMEDIATE trial. Prehosp Emerg Care. 2011 Apr-Jun;15(2):139-48. doi: 10.3109/10903127.2010.545478.
Kandzari DE, Zankar AA, Teirstein PS, Brilakis ES, Banerjee S, Price MJ, Stinis CT, Hudson PA, Dahle TG, Eng M, Brown R, Ferguson A, Addo TA, Popma JJ. Clinical outcomes following predilation with a novel 1.25-mm diameter angioplasty catheter. Catheter Cardiovasc Interv. 2011 Mar 1;77(4):510-4. doi: 10.1002/ccd.22734. Epub 2010 Nov 4.
Mahoney EM, Greenberg D, Lavelle TA, Natarajan A, Berezin R, Ishak KJ, Caro JJ, Yadav JS, Gray WA, Wholey MH, Cohen DJ. Costs and cost-effectiveness of carotid stenting versus endarterectomy for patients at increased surgical risk: results from the SAPPHIRE trial. Catheter Cardiovasc Interv. 2011 Mar 1;77(4):463-72. doi: 10.1002/ccd.22869.
Nazer B, Ray KK, Sloan S, Scirica B, Morrow DA, Cannon CP, Braunwald E. Prognostic utility of neopterin and risk of heart failure hospitalization after an acute coronary syndrome. Eur Heart J. 2011 Jun;32(11):1390-7. doi: 10.1093/eurheartj/ehr032. Epub 2011 Feb 22.
Shi L, Olson J, D’Agostino R Jr, Linville C, Nicolle MM, Robbins ME, Wheeler KT, Brunso-Bechtold JK. Aging masks detection of radiation-induced brain injury. Brain Res. 2011 Apr 18;1385:307-16. doi: 10.1016/j.brainres.2011.02.034. Epub 2011 Feb 19.
Demler OV, Pencina MJ, D’Agostino RB Sr. Equivalence of improvement in area under ROC curve and linear discriminant analysis coefficient under assumption of normality. Stat Med. 2011 May 30;30(12):1410-8. doi: 10.1002/sim.4196. Epub 2011 Feb 21.
Hivert MF, Sullivan LM, Shrader P, Fox CS, Nathan DM, D’Agostino RB Sr, Wilson PW, Kowall B, Herder C, Meisinger C, Thorand B, Rathmann W, Meigs JB. Insulin resistance influences the association of adiponectin levels with diabetes incidence in two population-based cohorts: the Cooperative Health Research in the Region of Augsburg (KORA) S4/F4 study and the Framingham Offspring Study. Diabetologia. 2011 May;54(5):1019-24. doi: 10.1007/s00125-011-2067-y. Epub 2011 Feb 19.
Cannon LA, Kereiakes DJ, Mann T, Popma JJ, Mooney MR, Mishkel GJ, Lee TC, Wilson BH, Stuckey TD, Orlow S, McGarry T, Ring ME, Kellett MA, Underwood P, Dawkins KD. A prospective evaluation of the safety and efficacy of TAXUS Element paclitaxel-eluting coronary stent implantation for the treatment of de novo coronary artery lesions in small vessels: the PERSEUS Small Vessel trial. EuroIntervention. 2011 Mar;6(8):920-7, 1-2. doi: 10.4244/EIJV6I8A161.
Resnic FS, Normand SL, Piemonte TC, Shubrooks SJ, Zelevinsky K, Lovett A, Ho KK. Improvement in mortality risk prediction after percutaneous coronary intervention through the addition of a “compassionate use” variable to the National Cardiovascular Data Registry CathPCI dataset: a study from the Massachusetts Angioplasty Registry. J Am Coll Cardiol. 2011 Feb 22;57(8):904-11. doi: 10.1016/j.jacc.2010.09.057.
Mathews R, Peterson ED, Chen AY, Wang TY, Chin CT, Fonarow GC, Cannon CP, Rumsfeld JS, Roe MT, Alexander KP. In-hospital major bleeding during ST-elevation and non-ST-elevation myocardial infarction care: derivation and validation of a model from the ACTION Registry®-GWTG™. Am J Cardiol. 2011 Apr 15;107(8):1136-43. doi: 10.1016/j.amjcard.2010.12.009. Epub 2011 Feb 15.
Hardy H, Kumar V, Doros G, Farmer E, Drainoni ML, Rybin D, Myung D, Jackson J, Backman E, Stanic A, Skolnik PR. Randomized controlled trial of a personalized cellular phone reminder system to enhance adherence to antiretroviral therapy. AIDS Patient Care STDS. 2011 Mar;25(3):153-61. doi: 10.1089/apc.2010.0006. Epub 2011 Feb 16.
Ahmed S, Michael Gibson C, Cannon CP, Murphy SA, Sabatine MS. Impact of reduced glomerular filtration rate on outcomes in patients with ST-segment elevation myocardial infarction undergoing fibrinolysis: a CLARITY-TIMI 28 analysis. J Thromb Thrombolysis. 2011 May;31(4):493-500. doi: 10.1007/s11239-011-0566-9.
Manzano-Fernández S, Januzzi JL Jr, Boronat-Garcia M, Bonaque-González JC, Truong QA, Pastor-Pérez FJ, Muñoz-Esparza C, Pastor P, Albaladejo-Otón MD, Casas T, Valdés M, Pascual-Figal DA. β-trace protein and cystatin C as predictors of long-term outcomes in patients with acute heart failure. J Am Coll Cardiol. 2011 Feb 15;57(7):849-58. doi: 10.1016/j.jacc.2010.08.644.
Mease PJ, Zimetbaum PJ, Duh MS, Vekeman F, Guérin A, Boerstoel-Streefland M, Jiang W, Lefebvre P. Epidemiologic Evaluation of Cardiovascular Risk in Patients Receiving Milnacipran, Venlafaxine, or Amitriptyline: Evidence from French Health Data. Ann Pharmacother. 2011 Feb;45(2):179-88. doi: 10.1345/aph.1P391.
Huffman JC, Mastromauro CA, Sowden GL, Wittmann C, Rodman R, Januzzi JL. A collaborative care depression management program for cardiac inpatients: depression characteristics and in-hospital outcomes. Psychosomatics. 2011 Jan-Feb;52(1):26-33. doi: 10.1016/j.psym.2010.11.021.
Kim JH, Noseworthy PA, McCarty D, Yared K, Weiner R, Wang F, Wood MJ, Hutter AM, Picard MH, Baggish AL. Significance of electrocardiographic right bundle branch block in trained athletes. Am J Cardiol. 2011 Apr 1;107(7):1083-9. doi: 10.1016/j.amjcard.2010.11.037. Epub 2011 Feb 4.
Konstantino Y, Morello A, Zimetbaum PJ, Josephson ME. Self-terminated ventricular fibrillation and recurrent syncope. Am J Cardiol. 2011 Feb 15;107(4):638-40. doi: 10.1016/j.amjcard.2010.10.025.
Mourtas S, Kastellorizios M, Klepetsanis P, Farsari E, Amanatides E, Mataras D, Pistillo BR, Favia P, Sardella E, d’Agostino R, Antimisiaris SG. Covalent immobilization of liposomes on plasma functionalized metallic surfaces. Colloids Surf B Biointerfaces. 2011 May 1;84(1):214-20. doi: 10.1016/j.colsurfb.2011.01.002. Epub 2011 Jan 7.
Burwitz BJ, Ende Z, Sudolcan B, Reynolds MR, Greene JM, Bimber BN, Almeida JR, Kurniawan M, Venturi V, Gostick E, Wiseman RW, Douek DC, Price DA, O’Connor DH. Simian immunodeficiency virus SIVmac239Deltanef vaccination elicits different Tat28-35SL8-specific CD8+ T-cell clonotypes compared to a DNA prime/adenovirus type 5 boost regimen in rhesus macaques. J Virol. 2011 Apr;85(7):3683-9. doi: 10.1128/JVI.02112-10. Epub 2011 Jan 26.
Navarese EP, De Servi S, Gibson CM, Buffon A, Castriota F, Kubica J, Petronio AS, Andreotti F, De Luca G. Early vs. delayed invasive strategy in patients with acute coronary syndromes without ST-segment elevation: a meta-analysis of randomized studies. QJM. 2011 Mar;104(3):193-200. doi: 10.1093/qjmed/hcq258. Epub 2011 Jan 23.
Baron SJ, Giugliano RP. Effectiveness and safety of percutaneous coronary intervention after fibrinolytic therapy for ST-segment elevation acute myocardial infarction. Am J Cardiol. 2011 Apr 1;107(7):1001-9. doi: 10.1016/j.amjcard.2010.11.024. Epub 2011 Jan 20.
George JC, Varghese V, Dangas G, Popma JJ. Transcatheter aortic valve implantation: lessons from the PARTNER (Placement of Aortic Transcatheter Valves) trial. JACC Cardiovasc Interv. 2011 Jan;4(1):132-3. doi: 10.1016/j.jcin.2010.12.002.
Szent-Gyorgyi LE, Coblyn J, Turchin A, Loscalzo J, Kachalia A. Building a departmental quality program: a patient-based and provider-led approach. Acad Med. 2011 Mar;86(3):314-20. doi: 10.1097/ACM.0b013e318209346e.
Applegate RJ, Yaqub M, Hermiller JB, Sood P, Yu S, Doostzadeh J, Williams JE, Farhat N, Caputo R, Lansky AJ, Cutlip DE, Sudhir K, Stone GW. Long-term (three-year) safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents (from the SPIRIT III Trial). Am J Cardiol. 2011 Mar 15;107(6):833-40. doi: 10.1016/j.amjcard.2010.10.069. Epub 2011 Jan 19.
Erkol A, Pala S, Kırma C, Oduncu V, Dündar C, Izgi A, Tigen K, Gibson CM. Relation of circulating osteoprotegerin levels on admission to microvascular obstruction after primary percutaneous coronary intervention. Am J Cardiol. 2011 Mar 15;107(6):857-62. doi: 10.1016/j.amjcard.2010.10.071. Epub 2011 Jan 19.
Alexander KP, Wang TY, Li S, Lytle BL, Slattery LE, Calhoun S, Poteat J, Roe MT, Rumsfeld JS, Cannon CP, Peterson ED. Randomized trial of targeted performance feedback to facilitate quality improvement in acute myocardial infarction care. Circ Cardiovasc Qual Outcomes. 2011 Jan 1;4(1):129-35. doi: 10.1161/CIRCOUTCOMES.110.958470.
Pal P, Rastogi SK, Gibson CM, Aston DE, Branen AL, Bitterwolf TE. Fluorescence sensing of zinc(II) using ordered mesoporous silica material (MCM-41) functionalized with N-(quinolin-8-yl)-2-[3-(triethoxysilyl)propylamino]acetamide. ACS Appl Mater Interfaces. 2011 Feb;3(2):279-86. doi: 10.1021/am100923x. Epub 2011 Jan 18.
Wilson PW, D’Agostino RB, Fox CS, Sullivan LM, Meigs JB. Type 2 diabetes risk in persons with dysglycemia: the Framingham Offspring Study. Diabetes Res Clin Pract. 2011 Apr;92(1):124-7. doi: 10.1016/j.diabres.2010.12.024. Epub 2011 Jan 15.
Uyarel H, Ergelen M, Cicek G, Kaya MG, Ayhan E, Turkkan C, Yıldırım E, Kırbas V, Onturk ET, Erer HB, Yesilcimen K, Gibson CM. Red cell distribution width as a novel prognostic marker in patients undergoing primary angioplasty for acute myocardial infarction. Coron Artery Dis. 2011 May;22(3):138-44. doi: 10.1097/MCA.0b013e328342c77b.
Longmore RB, Yeh RW, Kennedy KF, Anderson HV, White CJ, Longmore LS, Rosenfield K, Ho KK, Spertus JA. Clinical referral patterns for carotid artery stenting versus carotid endarterectomy: results from the Carotid Artery Revascularization and Endarterectomy Registry. Circ Cardiovasc Interv. 2011 Feb 1;4(1):88-94. doi: 10.1161/CIRCINTERVENTIONS.110.958843. Epub 2011 Jan 11.
Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJ, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J. 2011 Jan;32(2):205-17. doi: 10.1093/eurheartj/ehq406. Epub 2011 Jan 6.
Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJ, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol. 2011 Jan 18;57(3):253-69. doi: 10.1016/j.jacc.2010.12.005. Epub 2011 Jan 7.
Jensen JK, Hallén J, Lund T, Madsen LH, Grieg Z, Januzzi JL Jr, Atar D. Troponin I degradation in serum of patients with acute ischemic stroke. Scand J Clin Lab Invest. 2011 Feb;71(1):74-80. doi: 10.3109/00365513.2010.542485.
Booher AM, Isselbacher EM, Nienaber CA, Froehlich JB, Trimarchi S, Cooper JV, Demertzis S, Ramanath VS, Januzzi JL, Harris KM, O’Gara PT, Sundt TM 3rd, Pyeritz RE, Eagle KA; International Registry of Acute Aortic Dissection (IRAD) Investigators. Ascending thoracic aorta dimension and outcomes in acute type B dissection (from the International Registry of Acute Aortic Dissection [IRAD]). Am J Cardiol. 2011 Jan 15;107(2):315-20. doi: 10.1016/j.amjcard.2010.09.020.
Manzano-Fernández S, Mueller T, Pascual-Figal D, Truong QA, Januzzi JL. Usefulness of soluble concentrations of interleukin family member ST2 as predictor of mortality in patients with acutely decompensated heart failure relative to left ventricular ejection fraction. Am J Cardiol. 2011 Jan 15;107(2):259-67. doi: 10.1016/j.amjcard.2010.09.011.
Pencina MJ, D’Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011 Jan 15;30(1):11-21. doi: 10.1002/sim.4085. Epub 2010 Nov 5.
Held C, Asenblad N, Bassand JP, Becker RC, Cannon CP, Claeys MJ, Harrington RA, Horrow J, Husted S, James SK, Mahaffey KW, Nicolau JC, Scirica BM, Storey RF, Vintila M, Ycas J, Wallentin L. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. J Am Coll Cardiol. 2011 Feb 8;57(6):672-84. doi: 10.1016/j.jacc.2010.10.029. Epub 2010 Dec 30.
Charytan DM, Varma MR, Silbaugh TS, Lovett AF, Normand SL, Mauri L. Long-term clinical outcomes following drug-eluting or bare-metal stent placement in patients with severely reduced GFR: Results of the Massachusetts Data Analysis Center (Mass-DAC) State Registry. Am J Kidney Dis. 2011 Feb;57(2):202-11. doi: 10.1053/j.ajkd.2010.09.017. Epub 2010 Dec 24.
Cutlip DE, Mehran R, Vranckx P. FAME and coronary stent investigations: is there a kink in the wire?. J Am Coll Cardiol. 2011 Jan 4;57(1):115-6; author reply 116. doi: 10.1016/j.jacc.2010.07.041.
Chin CT, Chen AY, Wang TY, Alexander KP, Mathews R, Rumsfeld JS, Cannon CP, Fonarow GC, Peterson ED, Roe MT. Risk adjustment for in-hospital mortality of contemporary patients with acute myocardial infarction: the acute coronary treatment and intervention outcomes network (ACTION) registry-get with the guidelines (GWTG) acute myocardial infarction mortality model and risk score. Am Heart J. 2011 Jan;161(1):113-122.e2. doi: 10.1016/j.ahj.2010.10.004.
Spertus J, Dorian P, Bubien R, Lewis S, Godejohn D, Reynolds MR, Lakkireddy DR, Wimmer AP, Bhandari A, Burk C. Development and validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in patients with atrial fibrillation. Circ Arrhythm Electrophysiol. 2011 Feb;4(1):15-25. doi: 10.1161/CIRCEP.110.958033. Epub 2010 Dec 15.
Barringhaus KG, Zelevinsky K, Lovett A, Normand SL, Ho KK. Impact of independent data adjudication on hospital-specific estimates of risk-adjusted mortality following percutaneous coronary interventions in massachusetts. Circ Cardiovasc Qual Outcomes. 2011 Jan 1;4(1):92-8. doi: 10.1161/CIRCOUTCOMES.110.957597. Epub 2010 Dec 14.
Dabelea D, Dolan LM, D’Agostino R Jr, Hernandez AM, McAteer JB, Hamman RF, Mayer-Davis EJ, Marcovina S, Lawrence JM, Pihoker C, Florez JC. Association testing of TCF7L2 polymorphisms with type 2 diabetes in multi-ethnic youth. Diabetologia. 2011 Mar;54(3):535-9. doi: 10.1007/s00125-010-1982-7. Epub 2010 Nov 26.
Chiuve SE, Korngold EC, Januzzi JL Jr, Gantzer ML, Albert CM. Plasma and dietary magnesium and risk of sudden cardiac death in women. Am J Clin Nutr. 2011 Feb;93(2):253-60. doi: 10.3945/ajcn.110.002253. Epub 2010 Nov 24.
Martin-Doyle W, Essebag V, Zimetbaum P, Reynolds MR. Trends in US hospitalization rates and rhythm control therapies following publication of the AFFIRM and RACE trials. J Cardiovasc Electrophysiol. 2011 May;22(5):548-53. doi: 10.1111/j.1540-8167.2010.01950.x. Epub 2010 Nov 18.
Suh WM, Yeh RW, Watkins MT, Palacios IF. Inadvertent femoral endarterectomy: a complication from a suture-based vascular closure device. J Vasc Access. 2011 Jan-Mar;12(1):71-2. doi: 10.5301/jva.2010.6016.
Harrigan CJ, Peters DC, Gibson CM, Maron BJ, Manning WJ, Maron MS, Appelbaum E. Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging. Radiology. 2011 Jan;258(1):128-33. doi: 10.1148/radiol.10090526. Epub 2010 Nov 2.
Strom BL, Eng SM, Faich G, Reynolds RF, D’Agostino RB, Ruskin J, Kane JM. Comparative mortality associated with ziprasidone and olanzapine in real-world use among 18,154 patients with schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC). Am J Psychiatry. 2011 Feb;168(2):193-201. doi: 10.1176/appi.ajp.2010.08040484. Epub 2010 Nov 1.
Desai SP, Turchin A, Szent-Gyorgyi LE, Weinblatt M, Coblyn J, Solomon DH, Kachalia A. Routinely measuring and reporting pneumococcal vaccination among immunosuppressed rheumatology outpatients: the first step in improving quality. Rheumatology (Oxford). 2011 Feb;50(2):366-72. doi: 10.1093/rheumatology/keq297. Epub 2010 Oct 24.
Bonaca MP, Morrow DA, Braunwald E, Cannon CP, Jiang S, Breher S, Sabatine MS, Kempf T, Wallentin L, Wollert KC. Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: observations from PROVE IT-TIMI 22. Arterioscler Thromb Vasc Biol. 2011 Jan;31(1):203-10. doi: 10.1161/ATVBAHA.110.213512. Epub 2010 Oct 21.
Bangalore S, Kumar S, Wetterslev J, Bavry AA, Gluud C, Cutlip DE, Bhatt DL. Carotid artery stenting vs carotid endarterectomy: meta-analysis and diversity-adjusted trial sequential analysis of randomized trials. Arch Neurol. 2011 Feb;68(2):172-84. doi: 10.1001/archneurol.2010.262. Epub 2010 Oct 11.
de Miguel-Yanes JM, Shrader P, Pencina MJ, Fox CS, Manning AK, Grant RW, Dupuis J, Florez JC, D’Agostino RB Sr, Cupples LA, Meigs JB; MAGIC Investigators; DIAGRAM+ Investigators. Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms. Diabetes Care. 2011 Jan;34(1):121-5. doi: 10.2337/dc10-1265. Epub 2010 Oct 1.
Krishnaswamy A, Lincoff AM, Cannon CP. Bleeding complications of unfractionated heparin. Expert Opin Drug Saf. 2011 Jan;10(1):77-84. doi: 10.1517/14740338.2011.521150. Epub 2010 Sep 25.
Angiolillo DJ, Gibson CM, Cheng S, Ollier C, Nicolas O, Bergougnan L, Perrin L, LaCreta FP, Hurbin F, Dubar M. Differential effects of omeprazole and pantoprazole on the pharmacodynamics and pharmacokinetics of clopidogrel in healthy subjects: randomized, placebo-controlled, crossover comparison studies. Clin Pharmacol Ther. 2011 Jan;89(1):65-74. doi: 10.1038/clpt.2010.219. Epub 2010 Sep 15.
Turchin A, James OD, Godlewski ED, Shubina M, Coley CM, Gandhi TK, Broverman C. Effectiveness of interruptive alerts in increasing application functionality utilization: a controlled trial. J Biomed Inform. 2011 Jun;44(3):463-8. doi: 10.1016/j.jbi.2010.07.002. Epub 2010 Jul 15.
Dietrich M, Jacques PF, Polak JF, Keyes MJ, Pencina MJ, Evans JC, Wolf PA, Selhub J, Vasan RS, D’Agostino RB. Segment-specific association between plasma homocysteine level and carotid artery intima-media thickness in the Framingham Offspring Study. J Stroke Cerebrovasc Dis. 2011 Mar-Apr;20(2):155-61. doi: 10.1016/j.jstrokecerebrovasdis.2009.10.012. Epub 2010 Jun 26.
Reynolds MR, Willie JT, Zipfel GJ, Dacey RG. Sexual intercourse and cerebral aneurysmal rupture: potential mechanisms and precipitants. J Neurosurg. 2011 Apr;114(4):969-77. doi: 10.3171/2010.4.JNS09975. Epub 2010 Jun 11.
Pride YB, Frost EJ, Anderson PD, Cutlip DE. Precordial steering wheel: a fortunate accident. J Emerg Med. 2011 Oct;41(4):e83-7. doi: 10.1016/j.jemermed.2008.04.046. Epub 2008 Nov 20.